Nintedanib: Uses | 合法藥品大搜索

Nintedanibisatripleangiokinaseinhibitorindicatedforthetreatmentofidiopathicpulmonaryfibrosis,systemicsclerosis-associatedinterstitiallung ...

Nintedanib is indicated for the treatment of idiopathic pulmonary fibrosis (IPF)8 and to slow declining pulmonary function in patients with systemic sclerosis-associated interstitial lung disease.10 It is also indicated for the treatment of chronic fibrosing interstitial lung diseases with a progressive phenotype.10

In the EU, under the brand name Vargatef, nintedanib is indicated in combination with docetaxel for the treatment of adult patients with metastatic, locally advanced, or locally recurrent non-small cell lung cancer of adenocarcinoma histology who have already tried first-line therapy.9

Reduce drug development failure rates

Build, train, & validate machine-learning modelswith evidence-based and structured datasets.

Build, train, & validate predictive machine-learning models with structured datasets.

Prevent Adverse Drug Events Today

Tap into our Cli...